首頁 > 市場調查報告書 > 醫療設備

眼科設備

市場調查報告書

商品編碼

1522899

角膜移植市場規模、佔有率和成長分析：按適應症、類型、最終用戶和地區 - 產業預測，2024-2031 年

Corneal Transplant Market Size, Share, Growth Analysis, By Indications, By Type, By End-user, By Region - Industry Forecast 2024-2031

出版日期: 2024年07月16日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年角膜移植市場規模為4.558億美元，從2023年的4.8999億美元增加至2031年的8.7388億美元，複合年成長率預計為7.5%。

美國國立衛生研究院 (NIH) 報告稱，大約 10% 至 15% 的圓錐角膜患者可能需要角膜移植作為治療方法的一部分。這凸顯了角膜植入在控制和減少圓錐角膜影響方面的關鍵作用，而圓錐角膜影響了很大一部分人口。此外，角膜失明是一個重大的全球健康問題，是繼青光眼和白內障之後的第三大失明原因，估計影響全球 1,000 萬人。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Carl Zeiss Meditec AG（Germany）
Alcon, Inc.（Switzerland）
Bausch & Lomb Incorporated（United States）
Abbott Medical Optics, Inc.（United States）
CooperVision, Inc.（United States）
STAAR Surgical Company（United States）
Topcon Corporation（Japan）
Johnson & Johnson Vision Care, Inc.（United States）
Lumenis Ltd.（Israel）
NIDEK Co., Ltd.（Japan）
Haag-Streit AG（Switzerland）
Ziemer Ophthalmic Systems AG（Switzerland）
Essilor International SA（France）
Allergan, Inc.（Ireland）
HOYA Corporation（Japan）
Menicon Co., Ltd.（Japan）
Novartis AG（Switzerland）
SynergEyes, Inc.（United States）
Oculus, Inc.（United States）
ZEISS Group（Germany）

簡介目錄

Product Code: SQMIG35A2814

Corneal Transplant Market size was valued at USD 455.8 million in 2022 and is poised to grow from USD 489.99 million in 2023 to USD 873.88 million by 2031, growing at a CAGR of 7.5% in the forecast period (2024-2031).

According to a report from the National Institutes of Health (NIH), approximately 10-15% of patients diagnosed with keratoconus may require a corneal implant procedure as part of their treatment regimen. This highlights the critical role of corneal implants in managing and mitigating the effects of keratoconus, a condition that affects a significant portion of the population. Additionally, corneal blindness represents a significant global health issue, ranking as the third-leading cause of blindness after glaucoma and cataracts, impacting an estimated 10 million individuals worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Corneal Transplant market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Corneal Transplant Market Segmental Analysis

The corneal transplant market is segmented based on indication, type, end user, and region. Based on indications, the market is segmented into fungal corneal ulcer, bullous keratopathy, keratoconus, keratitis, corneal stromal dystrophies, and others. Based on type, the market is segmented into penetrating keratoplasty, endothelial keratoplasty, descemet stripping automated endothelial keratoplasty, corneal graft, corneal limbal stem cell transplant, and others. Based on end-user, the market is segmented into hospitals, eye clinics, and others. By region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Drivers of the Corneal Transplant Market

The corneal transplant market is experiencing substantial growth, driven primarily by the rising prevalence of conditions such as keratoconus, Fuchs dystrophy, keratitis, and cataracts, which often necessitate corneal transplantation as a crucial medical intervention. Data from the Eye Research Foundation in the US indicates a significant burden, with approximately 100,000 individuals affected by these conditions, including an estimated 50 to 200 individuals grappling with complex corneal diseases like keratoconus. This prevalence underscores the increasing demand for corneal implants, highlighting their essential role in treating various eye disorders.

Restraints in the Corneal Transplant Market

The corneal transplant market encounters notable obstacles due to the substantial expenses involved in treatment and a scarcity of donor tissue, which are significant constraints on its expansion. The costs associated with corneal transplantation, including pre-operative evaluations, surgical procedures, and post-operative management, impose a considerable financial burden on both patients and healthcare systems. This high cost can restrict accessibility, particularly in areas with limited healthcare infrastructure.

Market Trends of the Corneal Transplant Market

The remarkable expansion seen in the corneal transplant market stems from various factors contributing to heightened demand for these advanced treatments. One prevalent condition driving this growth is late-onset Fuchs endothelial corneal dystrophy, which predominantly affects individuals aged 40 and older, as reported in a March 2020 article in the journal Progress in Retina and Eye Research.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Start-up Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Global Corneal Transplant Market by Indication

Market Overview
Fungal corneal ulcer
Bullous keratopathy
Keratoconus
Keratitis
Corneal stromal dystrophies
Others

Global Corneal Transplant Market by Type

Market Overview
Penetrating keratoplasty
Endothelial keratoplasty
Descemet stripping automated endothelial keratoplasty (DSAEK)
Corneal graft
Corneal limbal stem cell transplant
Others

Global Corneal Transplant Market by End User

Market Overview
Hospitals
Eye clinics
Others

Global Corneal Transplant Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Carl Zeiss Meditec AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alcon, Inc. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch & Lomb Incorporated (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Medical Optics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperVision, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STAAR Surgical Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Topcon Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Vision Care, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lumenis Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NIDEK Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haag-Streit AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ziemer Ophthalmic Systems AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Essilor International S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan, Inc. (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HOYA Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Menicon Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SynergEyes, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oculus, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZEISS Group (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments